ArticleNucleic acids research2026
Sequence-directed covalent protein-RNA linkages in a single step using engineered HUH-tags.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Directed evolution of a sequence-specific covalent protein tag for RNA labeling.Proceedings of the National Academy of Sciences of the United States of America · 2025Article
Corrections and comments
- Update of
Authors and funding
11 authors.
Funding
Abstract
Replication-initiating HUH-endonucleases (reps) are enzymes that form covalent bonds with single-stranded DNA (ssDNA) in a sequence-specific manner to initiate rolling circle replication in plasmids and viruses. These nucleases have been co-opted for use in biotechnology as sequence-directed protein-ssDNA bioconjugation fusion partners dubbed 'HUH-tags'. Here, we describe the engineering and in vitro characterization of a series of laboratory evolved HUH-tag derivatives of PCV2 called E1 and E2. E2 is capable of forming robust covalent bonds with unmodified RNA substrates in a sequence-specific manner. We show that promiscuous rep-RNA interaction can be enhanced through directed evolution from nearly undetectable levels in wildtype enzymes to robust reactivity in final engineered iterations. Subsequent in vitro characterization revealed that engineered enzymes have dramatically increased activity on both cognate ssDNA and noncognate ssRNA substrates. We benchmark our engineered proteins against an engineered variant called rHUH described in recent work from another laboratory pursuing the same function, and we perform an extensive analysis of sequence specificity across a range of metal ion concentrations. Together, these results establish a new class of RNA-reactive HUH-tags that expand the biochemical repertoire of this enzyme family and provide a promising platform for site-specific protein-RNA covalent bioconjugation. This technology has the potential to unlock diverse new applications in biotechnology and molecular engineering.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.